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A B S T R A C T
In this study we analyzed one of the most comprehensive sets of 21 urinary phthalate metabolites representing
exposure to 11 parent phthalates (DEP, DMP, DiBP, DnBP, BBzP, DEHP, DiNP, DiDP, DCHP, DnPeP, DnOP) in
first morning urine samples of 112 Portuguese children (4–18 years) sampled in 2014/15. The study population
consisted of two groups: group 1 with normal weight/underweight children (N=43) following their regular diet
and group 2 with obese/overweight children (N=69) following a healthy diet (with nutritional counselling).
Most of the metabolites were above the limits quantification (81–100%) except for MCHP, MnPEP and MnOP.
Metabolite levels were generally comparable to other recent child and general populations sampled worldwide,
confirming the steady decline in exposures to most phthalates. Compared to Portuguese children sampled in
2011/2012, median urinary metabolite levels decreased by approximately 50% for DEHP, DnBP, DiBP and BBzP.
Risk assessments for individual phthalates and the sum of the anti-androgenic phthalates did not indicate to
attributable health risks, also at the upper percentiles of exposure. In the healthy diet group the median con-
centration of the DEHP metabolites was significant lower, while all phthalate metabolites except MEP tended to
be lower compared to the regular diet group. Multiple log-linear regression analyses revealed significantly lower
daily intakes (DIs) for all phthalates in the healthy diet group compared to the regular diet group (geometric
mean ratios (gMR) between 0.510–0.618; p≤ 0.05), except for DEP (gMR: 0.811; p= 0.273). The same analyses
with the continuous variable body mass index instead of the diet groups also showed effects on the DIs (gMRs
between 0.926–0.951; p≤ 0.05), however much smaller than the effects of the diet. The results indicate that
obese children following a healthy diet composed of fresh and less packaged/processed food can considerably
reduce their intake for most phthalates and can have lower phthalate intakes than regular weight/regular diet
children.
1. Introduction
Phthalates are dialkyl or alkyl esters of the ortho-benzene di-
carboxylic acid (phthalic acid). Depending on the length of the alkyl
chain, phthalates can be classified as low (LMW) or high (HMW) mo-
lecular weight phthalates (Koch and Calafat, 2009; Wittassek et al.,
2011). Di (2-ethylhexyl) phthalate (DEHP), di-iso-nonyl phthalate
(DiNP), and di-iso-decyl phthalate (DiDP) are HMW phthalates and
most frequently used as plasticizers in soft polyvinyl chloride (PVC) and
plastisol applications. LMW phthalates such as dimethyl phthalate
(DMP), diethyl phthalate (DEP), butyl benzyl phthalate (BBzP), di-n-
butyl phthalate (DnBP) and di-iso-butyl phthalate (DiBP) are frequently
used in personal care products, paints, adhesives or enteric-coated ta-
blets (Koch and Angerer, 2012; Koch and Calafat, 2009; Wittassek et al.,
2011). Diet is regarded as the main source of exposure to HMW
phthalates. For LMW phthalates dermal and inhalation exposures (e.g.
by product use, indoor air or dust) have been shown to be important
exposure routes next to diet/nutrition (Koch et al., 2011; Lorber et al.,
2016; Trasande et al., 2013b; Weschler et al., 2015; Zota et al., 2016).
Several phthalates, i.e. those with alkyl chain backbone lengths
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between 3–7 carbon atoms (ranging from DiBP to DiNP) are known
endocrine disruptors and developmental and reproductive toxicants in
rodents (Foster, 2006; Furr et al., 2014; Gray et al., 2016; Gray et al.,
2000; Hannas et al., 2011b; Lioy et al., 2015; van den Driesche et al.,
2015). Some epidemiological studies have directly linked phthalate
exposure to health effects in humans (Braun et al., 2013; Hauser et al.,
2016; Jurewicz and Hanke, 2011; Koch and Angerer, 2012; Swan,
2008; Swan et al., 2005). The European Union has successively classi-
fied several phthalates based on developmental effects and/or for fer-
tility effects and restricted the use of DEHP, DnBP, BBzP, DiBP, DiNP,
DiDP and DnOP (di-n-octyl phthalate) in toys and childcare articles
(Regulation (EC) No 1907/2006) (EU, 2006). Since February 2015,
phthalates listed in Annex XIV of the REACH regulation (currently
DiBP, DnBP, BBzP and DEHP) may only be placed on the European
market or used in the European Union if an authorization (for defined
and limited applications) has been granted (Regulations (EU) No 125/
2012 and (EU) No 143/2011) (EU, 2011, 2012). Furthermore, in 2017
the Committee for Risk Assessment (RAC) and the Committee for Socio-
Economic Analysis (SEAC) agreed on a restriction proposal on four
phthalates (DEHP, DnBP, DiBP and BBzP) in articles and on TDFA in
sprays used by the general public (ECHA, 2017).
Human biomonitoring studies have shown the worldwide exposure
to phthalates (CDC, 2017; Černá et al., 2015; Den Hond et al., 2015;
Frederiksen et al., 2013b; Health Canada, 2015; Kasper-Sonnenberg
et al., 2014; Koch and Calafat, 2009; Koch et al., 2017). Exposures to
most phthalates have been shown to considerably decrease over the
recent years probably due to regulatory measures and market changes
(Frederiksen et al., 2014; Gyllenhammar et al., 2017; Katsikantami
et al., 2016; Koch et al., 2017; Schoeters et al., 2017; Zota et al., 2014).
However, these studies also reveal differences in phthalate exposures
between countries/regions, between different ethnic groups, between
genders, and also in relation to age. Generally, children have been re-
ported to be exposed to most of the phthalates at higher levels than
adults (Den Hond et al., 2015; Frederiksen et al., 2014; Hartmann et al.,
2015; Kasper-Sonnenberg et al., 2012). Phthalate exposures of child
populations (including prenatal exposures) therefore remain in the
focus of scientific interest.
Several recent studies have examined associations of childhood
phthalate exposure and adiposity/obesity. Some studies report positive
associations between adiposity/obesity-related markers and childhood
phthalate exposures (Hatch et al., 2008) while others demonstrate in-
verse relationship between obesity-related markers in children and the
prenatal phthalate exposure (Buckley et al., 2016a, 2016b; Maresca
et al., 2016; Valvi et al., 2015) but also no or only small relationships
were detected (Buckley et al., 2016a, 2016b). A recent review by Braun
(2017) concluded that the results from studies linking phthalate ex-
posures and childhood obesity are inconsistent.
With this study we report on the recent (years 2014–2015) internal
exposure of Portuguese children (4–18 years old) to a set of the most
relevant phthalates (11 phthalates, 21 metabolites). Moreover we in-
vestigated possible differences in phthalate exposures between two
different groups of children in this study: one group (obese/overweight
children) that had been set on a healthy, calorie controlled diet in a
weight management program while the other group (normal weight/
underweight children) continued with their regular diet.
2. Material and methods
2.1. Study population
The present study is part of an ongoing study to assess possible
differences between obese/overweight and normal weight/under-
weight children in regard to exposure to environmental chemicals.
While at the onset of the study exposure to persistent endocrine dis-
ruptors and/or obesogens were in the focus, we included non-persistent
chemicals such as phthalates, phthalate substitutes and bisphenol A in a
later stage of the study. Principles of the study design are already given
in Lessmann et al. (2017) and et al. (2017a, 2017b); . Children were
recruited from the pediatric appointment at Hospital de S. João (obese/
overweight), and several local schools (normal weight/underweight), in
the years of 2014 and 2015. São João is a university general Hospital
focused on providing the best health care, with high levels of compe-
tence and excellence, encouraging training and research.
The children came from two Portuguese districts, Oporto and
Aveiro, belonging to the North and Central region of the country, re-
spectively. In all, one hundred and twelve children (55 boys, 57 girls)
participated in this study with an age range of 4–18 years (arithmetic
mean ± standard deviation: 10.4 ± 3.38 years old).
The children were divided in two groups: 1. Normal weight/un-
derweight children (N=43) following their usual regular diet (regular
diet group). 2. Obese/overweight children (N=69) that were coun-
selled for healthy and balanced nutrition and were set on a prescribed
diet based on fresh food and less packaged and processed food items
(healthy diet group). The adherence to the dietary recommendations
was confirmed by the nutritionist appointed to each child. The normal
weight/underweight and obese/overweight children were grouped ac-
cording to the WHO BMI charts (WHO, 2007). All children were not
hospitalized. The children in the weight management program pro-
vided their first morning urine samples after having been in the pro-
gram for approximately three months. The normal weight/underweight
children provided a first morning urine sample during a regular check
up at the hospital. Depending on the time of appointment some samples
were collected at home before the appointments. All the specimens
were kept cool during transportation and then stored at−20 °C until
analyses.
The study was approved by the ethics committee of the Centro
Hospitalar S. João/FMUP (Medicine Faculty of Oporto University ref.
163.13) and all the parents provided written consent.
2.2. Analysis of phthalate metabolites in urine
Urine samples were analyzed for 21 phthalate metabolites (re-
presenting the exposure to 11 parent phthalates) via on-line HPLC–MS/
MS with isotope dilution quantification after enzymatic deconjugation.
Details of the method and quality assurance were published elsewhere
(Kasper-Sonnenberg et al., 2012; Koch et al., 2003; Koch et al., 2017).
Briefly, 300 μL urine aliquots were added with 100 μL of 1M ammo-
nium acetate (at pH 6.0–6.4), 10 μL of internal standard and 6 μL of β-
glucoronidase (from E. coli strain K-12, without arylsulfatase activity,
diluted 1:1 in ammonium acetate buffer). The samples were gently
mixed and placed in water bath at 37 °C for 2 h. Then 10 μL of acetic
acid were added to adjust pH, and samples were frozen at −18 °C
overnight. The samples were then thawed and equilibrated at room
temperature and centrifuged at 1900× g for 10min, and 10 μL super-
natant were injected into an Agilent Technology LC 1260 system cou-
pled with an AB Sciex TripleQuad4500 tandem mass spectrometer. A
Capcell PAK 5 u C18 MG-II column for clean-up and enrichment and an
Atlantis d C18 (2.1×150mm; 3 μm) for chromatographic separation
were used, the two column assembly was operated in back-flush mode.
Detection was performed in negative ionization mode and quantifica-
tion was performed by isotope dilution with deuterium labeled internal
standards. Quality control materials (prepared from pooled native
urine) were included in each batch together with the study samples.
The phthalate metabolites analyzed (including the names of the re-
spective parent phthalates) are shown in Table S1 (Supplement mate-
rial). The sums of the metabolites of DiBP, DnBP, DEHP, DiNP, and
DiDP were calculated by summation (∑) of the corresponding metabo-
lite concentrations in μg/L.
2.3. Determination of urinary creatinine
Urinary creatinine was measured with a modified Jaffe method
(Jaffé, 1986) on an Olympus AU5400® (Beckman-Coulter®, Porto, Por-
tugal) at São João Hospital, Department of Clinical Pathology. Four out
of the 112 children had creatinine concentrations below 0.3 g/L.
However, all urine samples were included in the statistical analysis,
because creatinine concentrations below 0.3 g/L (WHO, 1996) (a cut-
off for adult populations) in children do not necessarily indicate ex-
cessive dilution, but can be indicative of lower muscle mass in children
compared to adults (Barr et al., 2005; Koch et al., 2011).
2.4. Daily intake estimation
Individual daily phthalate intakes (DI) were calculated from urinary
metabolites levels according to a creatinine based estimated models
published elsewhere (Koch et al., 2007; Wittassek et al., 2007) and were
adjusted to the height/age dependent reference values for creatinine
excretion (Remer et al., 2002). Supplemental Table S2 shows the factors
of urinary excretion (Fue) used for DI calculation.
2.5. Statistical analysis
Basic statistical analysis was performed using SPSS 20.0 (IBM
Corporation). Several statistical data is presented, such as median,
geometric and arithmetic means, maximum values and percentiles.
Concentrations below the LOQ were set to ½ LOQ (Lotz et al., 2013).
For the present analysis, age was divided in two groups in agreement
with the European regulations for clinical studies in pediatric patients
(ICH, 2000): (i) children from 2 to 11 years old; (ii) adolescents from 12
to 18 years old or was used as continuous variable for multiple log-
linear regression analyses (see below).
The non-parametric Mann-Whitney U test was performed to assess
possible differences across the distribution between region, sex, age,
and the two study groups (regular diet vs. healthy diet) for the urinary
metabolite concentrations (μg/L and μg/g creatinine) and the daily
intakes (μg/kg bw/day).
To analyze influences of important factors (e.g. diet groups, age,
sex) on the DIs, we performed multiple log-linear regression analysis
using the ln-transformed DIs of the phthalates (μg/kg bw/day) as de-
pendent variable. The changes of the DIs by a unit change of the in-
dependent variables are presented as geometric mean ratios (gMR)
together with their corresponding 95% confidence intervals (95% CI)
which can be interpreted similar to Odds Ratios. For this purpose the
regression coefficients beta were back-transformed on their natural
scale (exp (beta)). This part of the analysis was performed with the
statistical software SAS 9.4 © SAS Institute Inc., Cary, NC, USA.
2.6. Cumulative risk assessment
For cumulative risk assessment we applied the approach as de-
scribed by the Chronic Hazard Advisory Panel (CHAP) on Phthalates
and Phthalate Alternatives (CHAP, 2014; Lioy et al., 2015).
In short, the CHAP derived potency estimates for anti-androgenicity
(PEAA, expressed as daily intakes in μg/kg/day) for the individual
phthalates. Five phthalates, known to possess anti-androgenic potency,
were included in the calculations (BBzP, DiBP, DnBP, DEHP and DiNP).
Because the CHAP had to fall back on different studies, the CHAP
decided to base their calculations on three different cases. Case 1 in-
cludes health benchmark values used in a cumulative risk assessment
for mixtures of phthalates and other endocrine disruptors (Kortenkamp
and Faust, 2010), case 2 includes values derived from a more recent
mixture study of phthalates in rats enabling a direct comparison of
potencies (Hannas et al., 2011b), and case 3 includes values from
CHAP`s de novo literature review of reproductive and developmental
endpoints focused on reliable no observed adverse effect levels
(NOAELs) and Points of departure (PODs) (see Supplementary Table S3
for the used PEAAs).
For each case, and each phthalate, the Hazard Quotient (HQ) was
calculated as the ratio of exposure (estimate of daily intake) to the
respective PEAA (see Eq. (2.1)). The HI is the sum of the individual HQs
(see Eq. (2.2)):
=Hazard Quotient(HQ )
DI (μg/kg/day)
PEAA (μg/kg/day)j
j
j (2.1)
∑=
=
QHazard index(HI) H jc
j 1
(2.2)
A HQ or a HI of larger than 1 indicates that individual (HQ) or
cumulative (HI) exposure levels are higher than levels deemed accep-
table; adverse health effects cannot be excluded anymore with suffi-
cient certainty.
3. Results
The total study population of 112 children was composed of 49 %
boys and 51 % girls, with a median age of 10 years old. The majority of
the children was overweight/obese and underwent a diet with nutri-
tional guidance (healthy diet group) (62 %; n=69). From the 43
children of the regular diet group 42 were normal weight and only one
child was underweight. A summary of anthropometric data of the study
population, including the two groups is given in Table 1. The dis-
criminators body weight and BMI differed significantly between the two
groups but age, sex, height and urinary creatinine were equally dis-
tributed (Table 1).
3.1. Urinary metabolite levels
The concentrations of the 21 phthalate metabolites (representing
exposure to 11 parent phthalates) in urine samples of the 112
Portuguese children are depicted in Table 2 (in μg/L) and in
Table 1
Characteristics of the study population.
Population characteristics Total (n= 112) Regular diet (n= 43)a Healthy diet (n= 69)a p value*
Normal weight/underweight Overweight/obese
No nutritional guidance Nutritional guidance
Median P95 Max. Median P95 Max. Median P95 Max.
Age (years) 10.0 16.4 18.0 11.0 17.0 18.0 9.00 16.0 17.0 0.426
Sex (%) 51% Female 44% Female 55% Female 0.265
49% Male 56% Male 45% Male
Weight (kg) 44.7 80.6 120 34.8 64.8 75.0 45.5 82.3 120 <0.001
Height (cm) 142 171 184 143 181 184 142 168 182 0.643
BMI (kg/m2) 22.2 30.3 42.3 17.1 23.0 24.1 24.6 34.2 42.3 <0.001
Creatinine (g/L) 0.94 2.59 3.81 0.88 2.55 2.64 0.98 2.79 3.81 0.907
a The underweight/normal weight and obese/overweight groups were defined according to the WHO charters (WHO, 2007); P95–95th percentile; Max. – Maximum value.
* Mann-Whitney-U test, 2-tailed; Significant differences between the regular and healthy diet groups (p≤ 0.05) are marked in bold.
Supplementary Table S4 (creatinine adjusted concentrations). Almost
all metabolites were detected in the majority of the samples (detection
rates from 81 to 100%). Only for MnPeP, MCHP and MnOP detection
rates were below 10%. These metabolites were excluded from further in
depth investigation.
For the LMW phthalates the DEP metabolite MEP was present at
highest median concentrations (59.4 μg/L), followed by the metabolites
of DiBP (∑23.7 μg/L), DnBP (∑14.2 μg/L), MMP (3.16 μg/L) and MBzP
(2.27 μg/L). For the HMW phthalates, DEHP metabolites were detected
at highest median concentrations (∑DEHP 40.4 μg/L), followed by DiNP
(∑DiNP 13.9 μg/L) and DiDP (∑DiDP 3.59 μg/L).
A comparison of urinary metabolite levels determined in this study
with other studies on child populations is presented in Supplementary
Table S5. Both urinary levels and metabolite distributions are roughly
within the same order of magnitude. Compared to Portuguese children
of the European-wide DEMOCOPHES study (Den Hond et al., 2015),
with samples collected in 2011/12, median urinary metabolite levels in
our study are approximately 50% lower for DEHP, DnBP, DiBP and
BBzP.
In regard to sex, we found only MEP metabolite levels were sig-
nificantly higher in girls with approximately 50% higher urinary MEP
concentrations (p≤ 0.05; both in μg/L and after creatinine adjust-
ment). In regard to age (4–11 years vs. 12–18 years) we found ap-
proximately two-fold higher MMP and MEP levels in the older children
(p≤ 0.05 for values in μg/L), however with no statistical difference
after creatinine adjustment (data not shown). These findings point to
increased personal care product use in older children, especially girls.
The urinary phthalate metabolite concentrations for the two groups
of children (regular diet group and healthy diet group) are presented in
the Supplementary Tables S6–S9 in μg/L and μg/g creatinine. A com-
parison between the two groups, based on median urinary metabolite
levels (multiple metabolites per phthalate summed up), is depicted in
Table 3.
For nearly all metabolites (resp. summed metabolites) median
concentrations (both in μg/L and μg/g creatinine) were higher in the
regular diet group compared to the healthy diet group. However, these
differences reached statistical significance (p≤ 0.05) only for the DEHP
metabolites (∑DEHP 47.0 μg/L vs. 29.2 μg/L and 48.9 μg/g vs. 35.0 μg/
g). DEP was the only exception, with the healthy diet group (obese/
overweight children) excreting slightly higher urinary MEP levels than
the regular diet group (normal weight/underweight children).
Table 2
Urinary phthalate metabolite concentrations (in μg/L) in the total study population (n=112).
Parent Phthalate Metabolite LOQ % μg/L
[μg/L] ≥LOQ Geom. Mean 95% Confidence interval Median P95 Max.
DMP MMP 1.00 91.0 3.10 2.60–3.70 3.16 13.0 54.5
DEP MEP 0.50 100 58.3 46.6–72.9 59.4 494 1310
BBzP MBzP 0.20 96.0 2.25 1.78–2.81 2.27 30.3 68.5
DCHP MCHP 0.20 5.00 < LOQ <LOQ <LOQ 0.24 0.56
DnPEP MnPeP 0.20 0.00 < LOQ <LOQ <LOQ <LOQ <LOQ
DiBP MiBP 1.00 99.0 16.8 14.4–19.6 16.9 68.4 195
OH-MiBP 0.25 100 6.54 5.56–7.70 7.08 28.0 57.6
∑DiBP 23.5 20.1–27.6 23.7 94.0 248
DnBP MnBP 1.00 99.0 12.8 10.6–15.1 12.7 55.4 80.4
OH-MnBP 0.25 97.0 1.67 1.40–1.97 1.92 6.95 14.0
∑DnBP 14.6 12.1–17.2 14.2 63.0 94.4
DEHP MEHP 0.50 87.0 1.90 1.52–2.37 2.02 12.2 70.8
OH-MEHP 0.20 100 10.9 9.23–13.0 11.5 58.2 183
oxo-MEHP 0.20 100 7.62 6.47–9.03 8.39 37.9 112
cx-MEPP 0.20 100 16.1 13.8–19.0 17.4 68.8 281
∑DEHP 37.3 31.8–44.0 40.4 170 639
DiNP OH-MiNP 0.20 99.0 5.57 4.51–6.79 5.47 38.8 98.0
oxo-MiNP 0.20 97.0 2.23 1.74–2.80 2.03 31.7 61.2
cx-MiNP 0.20 100 7.42 6.12–9.03 6.99 44.5 137
∑DiNP 15.8 13.0–19.2 13.9 118 250
DiDP OH-MiDP 0.20 94.0 1.31 1.06–1.59 1.34 8.69 14.6
oxo-MiDP 0.20 93.0 0.71 0.59–0.84 0.71 4.15 12.2
cx-MiDP 0.20 100 1.19 1.04–1.38 1.17 4.88 10.8
∑DiDP 3.38 2.87–3.97 3.59 19.9 27.3
DnOP MnOP 0.20 0.00 < LOQ <LOQ <LOQ <LOQ <LOQ
various MCPPa 0.50 81.0 1.03 0.87–1.22 1.03 4.81 15.1
aMCPP is a metabolite of several HMW and LMW phthalates (currently known: DnBP, DnPeP, DnOP, DiNP, DiDP) LOQ – Limit of quantification; Geom. Mean – geometric mean; Max. –
Maximum value; P95–95th percentile.
Table 3
Differences of the phthalate metabolite concentrations between the regular and healthy
diet groups.
Metabolites Group μg/L μg/g creatinine
Median p value* Median p value*
MMP regular diet 3.59 0.193 3.83 0.136
healthy diet 2.83 3.10
MEP regular diet 52.4 0.424 60.6 0.378
healthy diet 60.8 64.3
MBzP regular diet 2.46 0.163 2.78 0.206
healthy diet 2.01 2.22
∑DiBP regular diet 29.3 0.168 31.8 0.179
healthy diet 21.5 22.2
∑DnBP regular diet 15.1 0.785 18.0 0.753
healthy diet 14.1 15.3
∑DEHP regular diet 47.0 0.016 48.9 0.007
healthy diet 29.2 35.0
∑DiNP regular diet 16.2 0.265 17.4 0.155
healthy diet 12.8 11.7
∑DiDP regular diet 3.83 0.130 3.82 0.102
healthy diet 3.03 3.19
MCPP regular diet 1.35 0.184 1.22 0.251
healthy diet 0.86 0.87
Regular diet n=43; healthy diet n=69.
* Mann-Whitney-U test, 2 tailed; significant differences between the regular and
healthy diet groups (p≤ 0.05) are marked in bold.
3.2. Calculated daily intakes (DI)
Daily intakes (median, 95th percentile and maximum values in μg/
kg bw/day) calculated separately for both groups are shown in Table 4.
DEHP was the phthalate with the highest median DI (1.89 μg/ kg bw/
day) followed by DEP, DiNP, DiBP, DnBP, DiDP, with lowest intakes for
DMP and BBzP. For all phthalates, median DIs were around 1.5–2 times
higher for children on the regular diet than for children on the healthy
diet (e.g. for ∑DEHP 2.79 μg/kg bw/day vs. 1.41 μg/kg bw/day or
∑DiBP 0.78 μg/kg bw/day vs. 0.41 μg/kg bw/day, respectively). These
differences were statistically significant, except for DEP (p=0.394).
3.3. Predictors of the body burden
In a log-linear regression analysis we found that daily intakes were
significantly associated with the healthy diet group for all of the
phthalates, except for DEP (Table 5). Compared to the regular diet
group the healthy diet group had between 38 % (DiNP) to 49 % (DEHP)
lower DIs (Fig. 1). Furthermore, age was negatively associated with
DiBP, DnBP, DEHP, and DiNP. This is in line with the already known
higher phthalate DI in younger children. However, the changes are
rather low and lie between 2% to 7%. Sex emerged as a significant
factor on the DI only for DEP. The girls had a 55% higher DI than the
boys which is most likely related to the higher use of cosmetics in the
girls.
In a second log-linear regression analysis, we also tested whether
the continuous variable BMI instead of the two diet groups has an effect
on the DI of phthalates (Table 6). Indeed, the BMI was significantly and
negatively associated with the DI for all phthalates, except for DEP.
However, compared to the predicted changes on the DIs between the
healthy diet group versus the regular diet group, these changes were
considerably lower (about 7% to 5% lower DIs with increasing BMI).
With this additional analysis we can demonstrate that the BMI is ne-
gatively associated with the DI within our study but this effect is much
smaller than the effect of the healthy diet in the two study groups.
3.4. Risk assessment
A risk assessment of exposure to phthalates can be performed for
each phthalate individually or on a cumulative basis, taking account of
Table 4
Calculated daily phthalate intakes for the total study population and the regular and healthy diet group.
Phthalates Group Daily intake (μg/kg bw/day)
Geometric
Mean
95% Confidence interval Median P95 Max p value*
DMP total 0.08 0.07–0.09 0.07 0.36 1.44 –
regular diet 0.12 0.09–0.15 0.10 0.74 1.16 <0.001
healthy diet 0.07 0.05–0.08 0.06 0.24 1.44
DEP total 1.62 1.36–1.94 1.46 10.7 44.2 –
regular diet 1.79 1.31–2.58 1.55 20.2 44.2 0.394
healthy diet 1.52 1.23–1.88 1.39 8.08 17.7
BBzP total 0.06 0.05–0.08 0.07 0.40 1.15 –
regular diet 0.09 0.07–0.12 0.09 0.43 1.15 0.005
healthy diet 0.05 0.04–0.07 0.05 0.38 0.98
DiBP total 0.54 0.46–0.62 0.51 1.95 9.12 –
regular diet 0.75 0.59–0.97 0.78 2.91 9.12 0.001
healthy diet 0.43 0.37–0.51 0.41 1.38 2.08
DnBP total 0.28 0.23–0.32 0.27 1.03 2.60 –
regular diet 0.40 0.31–0.50 0.48 1.86 2.60 0.001
healthy diet 0.22 0.18–0.27 0.25 0.78 1.35
DEHP total 1.74 1.49–2.02 1.89 6.61 24.0 –
regular diet 2.60 2.14–3.14 2.79 7.19 9.38 <0.001
healthy diet 1.35 1.12–1.65 1.41 5.51 24.0
DiNP total 1.18 0.99–1.42 1.04 6.77 41.7 –
regular diet 1.55 1.22–1.96 1.32 6.74 14.4 0.002
healthy diet 1.00 0.79–1.29 0.72 7.06 41.7
DiDP total 0.27 0.23–0.31 0.26 1.11 1.65 –
regular diet 0.38 0.30–0.46 0.35 1.17 1.65 <0.001
healthy diet 0.22 0.18–0.26 0.20 1.15 1.42
Max. – Maximum value; P95–95th percentile; Mann-Whitney-U test, 2 tailed; significant differences between the regular and healthy diet groups (p≤ 0.05) are marked in bold.
Table 5
Influences of covariates (diet groups, age, sex) on the daily intake of phthalates. Log-
linear regression analyses using ln-transformed daily intakes of phthalates (μg/kg bw/d)
as dependent variable.
Healthy diet vs.
regular diet
Age (years) Sex (female vs.
male)
DMP gMR 0.563** 1.005 0.999
95% CI (lower;
upper)
0.412; 0.770 0.961; 1.051 0.738; 1.352
DEP gMR 0.811 0.978 1.550*
95% CI (lower;
upper)
0.558; 1.179 0.927; 1.033 1.080; 2.223
BBzP gMR 0.558* 0.968 0.831
95% CI (lower;
upper)
0.369; 0.844 0.912; 1.028 0.557; 1.240
DiBP gMR 0.523*** 0.926*** 1.277
95% CI (lower;
upper)
0.402; 0.680 0.892; 0.962 0.991; 1.647
DnBP gMR 0.517*** 0.951* 0.995
95% CI (lower;
upper)
0.378; 0.707 0.909; 0.995 0.736; 1.345
DEHP gMR 0.510*** 0.952* 0.835
95% CI (lower;
upper)
0.383; 0.678 0.913; 0.992 0.634; 1.101
DiNP gMR 0.618* 0.948* 0.991
95% CI (lower;
upper)
0.430; 0.888 0.899; 0.999 0.698; 1.407
DiDP gMR 0.575** 0.981 0.953
95% CI (lower;
upper)
0.430; 0.770 0.940; 1.023 0.719; 1.264
gMR=geometric mean ratio= exp(β); 95% CI: 95% confidence interval= exp(lower
limit of β) and exp (upper limit of β).
* p≤ 0.05.
** p≤ 0.001.
*** p≤ 0.0001.
concurrent phthalate exposures. For individual phthalates human bio-
monitoring assessment values have been derived based on the con-
centration of phthalate metabolites that are consistent with existing
health-based exposure limit values such as the tolerable daily intake
(TDI) or a reference dose (RfD). These values are either called
Biomonitoring Equivalents (BE), derived by Summit Toxicology
(Aylward et al., 2009a, 2009b; Hays and Aylward, 2009; Hays et al.,
2011; Hays et al., 2007) or Human-Biomonitoring-Values (HBM-va-
lues), derived by the German Human Biomonitoring Commission
(Angerer et al., 2011; Apel et al., 2016; Schulz et al., 2011, 2012).
Urinary phthalate metabolites determined in the current study com-
pared to these human biomonitoring assessment values are depicted in
Table 7.
Median urinary metabolite concentrations were considerably below
human biomonitoring assessment values for all phthalates, ranging
between 0.07% of the BE of BBzP and 8.5% of the BE of DEHP. Also, at
the 95th Percentile all urinary metabolites were consistently below the
respective BE/HBM-I-values. The DEHP metabolites reflect 40.8% of
the BE, followed by DnBP with 27.7% and DiNP with 6.6% of the BE.
Only one child (from the healthy diet group) exceeded the BE for DEHP
by a factor of 1.38.
We made similar observations comparing calculated DIs for the
various phthalates in the Portuguese children with health benchmark
doses for the respective phthalates (see Supplementary Table S10). The
US EPA RfD for DEHP (20 μg/kg bw/day) was exceeded only by one
child (same child as above) with a calculated daily intake of 24 μg/kg
bw/day. At the 95th percentile, like for urinary metabolite levels, cal-
culated DIs were consistently below respective health benchmark doses,
with DEHP intakes reflecting 13.2% of the TDI and 33.1% of the RfD,
while DnBP intakes reflecting 13.7% of the TDI and 1.4% of the RfD.
DiNP and DiDP intakes reflect 4.5% and 0.7% of the TDI (nor RfD de-
rived), respectively.
To evaluate the risk of the cumulative phthalate exposure we ap-
plied the Hazard Index (HI) approach as described by the Chronic
Hazard Advisory Panel (CHAP) on Phthalates (CHAP, 2014; Lioy et al.,
2015). This approach takes into account the common anti-androgenic
mode of action in rodents as one of the critical effects of BBzP, DiBP,
DnBP, DEHP and DiNP. The three cases used by CHAP for potency es-
timate derivation are depicted in Supplementary Table S3. Based on
these PEAAs (three cases) we calculated the HIs for anti-androgenicity
(Table 8). A HI > 1 indicates to cumulative exposure levels to the
phthalates investigated that cannot be regarded as safe anymore.
In none of the three cases the HI exceeded the value of 1 (maximum
HI: 0.81). At the 95th percentile the HIs were between 0.12 and 0.27. At
the median, the values ranged between 0.03 and 0.10. Irrespective of
Fig. 1. Changes on the DIs of phthalates for children in the healthy diet group compared to children in the regular diet group (multiple log-linear regression analyses, adjusted for age and
sex).
Table 6
Influences of covariates (body mass index, age, sex) on the daily intake of phthalates. Log-
linear regression analyses using ln-transformed daily intakes of phthalates (μg/kg bw/d)
as dependent variable.
BMI (kg/m2) Age (years) Sex (female vs.
male)
DMP gMR 0.928*** 1.053* 0.904
95% CI (lower;
upper)
0.902; 0.955 1.007;
1.102
0.678; 1.204
DEP gMR 0.970 0.997 1.491*
95% CI (lower;
upper)
0.936; 1.006 0.942;
1.054
1.043; 2.132
BBP gMR 0.930** 1.014 0.752
95% CI (lower;
upper)
0.894; 0.967 0.954;
1.078
0.510; 1.109
DiBP gMR 0.935*** 0.968 1.153
95% CI (lower;
upper)
0.912; 0.959 0.931;
1.007
0.898; 1.480
DnBP gMR 0.929*** 0.998 0.893
95% CI (lower;
upper)
0.902; 0.956 0.953;
1.045
0.667; 1.196
DEHP gMR 0.926*** 1.000 0.747*
95% CI (lower;
upper)
0.902; 0.951 0.959;
1.043
0.574; 0.973
DiNP gMR 0.951* 0.979 0.918
95% CI (lower;
upper)
0.919; 0.985 0.927;
1.034
0.649; 1.300
DiDP gMR 0.942*** 1.020 0.872
95% CI (lower;
upper)
0.916; 0.968 0.976;
1.065
0.661; 1.149
gMR=geometric mean ratio= exp(β); 95% CI: 95% confidence interval= exp(lower
limit of β) and exp (upper limit of β).
* p≤ 0.05.
** p≤ 0.001.
*** p≤ 0.0001.
the three calculation cases, median HIs of the healthy diet group were
approximately half the median HIs of the regular diet group. Depending
on the cases, either DEHP or DnBP was the major contributor to the HI
(data not shown).
4. Discussion
4.1. Exposure and risk assessment
With this study we provide urinary excretion data for one of the
most comprehensive sets of biomarkers of phthalate exposure (21
phthalate metabolites representing exposure to 11 parent phthalates).
All children investigated were simultaneously exposed to a wide range
of both LMW and HMW phthalates. Specific urinary metabolites of DEP,
DiBP, DnBP, DEHP, DiNP and DiDP were quantifiable in ≥99% of all
samples, followed by BBzP (96%) and DMP (91%). DCHP was detected
only in 5% of the samples, generally at very low levels, and DnOP in
none. DnPeP, one of the most critical phthalates in terms of anti-an-
drogenicity (Hannas et al., 2011a) and only recently included in some
biomonitoring studies (Silva et al., 2011), could not be detected in any
sample analyzed.
In general, urinary metabolite levels quantified in this study are in
the same order of magnitude as levels quantified in other studies on
children in Europe, America and Asia (see Supplemental Table S5). For
the LMW phthalate DMP and the HMW phthalates DiNP and DiDP,
included only in few previous human biomonitoring studies on chil-
dren, we provide first data for Portugal. DiNP and DiDP have been
strictly regulated with regard to its use in children’s toys and childcare
articles in Europe and recently also in the US (CPSC, 2017). With our
data we can confirm the ubiquitous exposure of children to these
phthalates as reported previously for Germany, Sweden, Denmark and
the US. However, some differences in urinary phthalate levels between
countries and/or regions can still be observed. Den Hond et al. (2015)
showed for Europe, that phthalate biomarker data clustered together by
geographical grouping with the Southern European countries (Spain,
Portugal) building their own cluster with generally higher urinary DEP
and DEHP metabolite levels in these countries. These clusters and dif-
ferences in exposure are probably due to different life-style habits,
different product uses, or different market uses of the various phtha-
lates in the different regions. We could confirm this by rather high DEP
metabolite levels in our study population for Portugal. For DEP, Den
Hond et al. (2015) identified the use of personal care products as the
major determinant of exposure, in line with other studies (Larsson
et al., 2014; Sathyanarayana et al., 2008b). Compared to the metabolite
levels of Portuguese children in 2011/12, reported by Den Hond et al.
(2015), most phthalate metabolites levels in this study, with samples
collected in 2014/2015, are considerably lower (by a factor of 2–3).
This is in accordance with the general decline in exposure observed for
these phthalates over the recent years, due to regulatory measures,
changes in market use, and the substitution of phthalates by non-
phthalate alternatives (Correia-Sá et al., 2017b; Frederiksen et al.,
2014; Gyllenhammar et al., 2017; Koch et al., 2017; Lessmann et al.,
2017; Schoeters et al., 2017; Zota et al., 2014). For DEHP diet is gen-
erally considered the major route of exposure, for the LMW phthalates
other sources such as consumer and personal care products use and
indoor environment seem to be of additional relevance (Koch et al.,
2013; Wormuth et al., 2006).
The risk assessment of exposure to the individual phthalates, either
by comparing urinary metabolite levels with human biomonitoring
assessment values (BE, HBM-I) or by comparing calculated daily intakes
with health benchmark doses (TDI, RfD) resulted in similar findings,
confirming that current exposure levels in this study population (with
samples collected in 2014/2015) were consistently below these
benchmark levels both at the median and in the upper percentiles. Only
one child slightly exceeded the US EPA RfD derived benchmark level for
DEHP. For DEHP and DnBP substantial and frequent exceedances of
these health benchmarks have been reported in samples collected be-
fore the turn of the millennium (Koch et al., 2017) or in child popu-
lations sampled at the beginning of this millennium. In 239 children
sampled in 2001/2002 as a pilot study of the German Environmental
Survey on Children (GerES IV) health benchmark values were exceeded
in up to 7.5 % of the children for DEHP (Wittassek et al., 2007) and in
up to 37% of the children for DnBP (Koch et al., 2007).
Table7
Humanbiomonitoringassessmentvalues(BEandHBM)incomparisontourinarymetaboliteconcentrationsmeasuredinthePortuguesechildren.
Phthalate Human biomonitoring assessment values Urinary metabolite concentrations in the Portuguese children
Total Regular diet Healthy diet
Type Biomarkers/metabolites Value
(in μg/L)
Median P95 Max Median P95 Max Median P95 Max
DEP BEa MEP 18000 59.4 494 1310 52.4 750 1310 60.8 397 965
BBzP BEa MBzP 3800 2.27 30.3 68.5 2.46 14.5 68.5 2.01 36.2 44.5
DnBP BEa,b MnBP 200 12.7 55.4 80.4 12.9 53.1 56.0 12.7 57.1 80.4
DEHP HBM-Ic,d,e 5OH-MEHP+5oxo-MEHP 500 19.7 96.8 295 23.3 88.8 97.8 14.4 106 295
BEf,g MEHP+5OH-MEHP+5oxo-MEHP 260 22.2 106 358 26.6 95.2 114 17.4 118 358
DiNP BEh OH-MiNP+oxo-MiNP+ cx-MiNP 1800 13.9 118 250 16.2 92.9 122 12.8 182 250
Exceedances highlighted in bold.
a Aylward et al. (2009a).
b Based on EFSA TDI (EFSA, 2005b).
c Schulz et al. (2012).
d Based on EFSA TDI of 50 μg/kg/d (EFSA, 2005a).
e Children 6–13 years.
f Aylward et al. (2009b).
g Based on US EPA RfD of 20 μg/kg/d (EPA).
h DiNP:(Hays et al., 2011).
Table 8
Hazard Indices (HI) for the Portuguese children, separately for the two groups of children.
Group Median P95 Maximum
HI (case 1) Regular diet 0.10 0.26 0.37
Healthy diet 0.05 0.20 0.81
HI (case 2) Regular diet 0.10 0.25 0.41
Healthy diet 0.06 0.27 0.53
HI (case 3) Regular diet 0.06 0.16 0.20
Healthy diet 0.03 0.12 0.49
Regular diet- Normal weight/underweight on regular diet; Healthy diet – Obese/over-
weight with nutritional guidance.
The cumulative risk assessment based on the Hazard Index (HI)
approach as described by the CHAP, taking into account the common
anti-androgenic mode of action of phthalates (NRC, 2008) with three to
nine carbon atoms in their alkyl side chain (DiBP, DnBP, BBzP, DEHP,
DiNP) revealed no exceedance of the HI of 1. The highest HI observed
was 0.81. Thus, we can assume that there is no attributable risk to anti-
androgenic effects from the cumulative exposure to the phthalates in-
vestigated in this study. The CHAP, based on urinary metabolite data
from NHANES (2005-06) and a mother-child cohort (SFF, sampling
from 1999 to 2005) (Sathyanarayana et al., 2008a) found exceedances
of the HI of 1.0 in about 10 % of pregnant women in the NHANES
population and in about 4–5 % of mothers and infants in the SFF (Lioy
et al., 2015). A recent application of the CHAP HI model to NHANES
data from 2013/14 performed by the US CPSC (CHAP, 2017) found HI
values> 1 only in less than 1–1.2 %, depending on the calculation case.
Frederiksen et al. (2013b) and Hartmann et al. (2015) calculated HI
values for cumulative phthalate exposure in their population of chil-
dren. These calculations are not directly comparable to the CHAP model
because EFSA TDI’s were used as potency estimates, which are not fully
comparable to CHAPs anti-androgenicity based potency estimates. For
Denmark, Frederiksen et al. (2013b) reported that more than 5 % of the
children exceeded the HI of 1 with a maximum HI of 4.35. For Austria,
Hartmann et al. (2015) reported that 4 % of the children aged 7–15
years had HIs larger than 1, based on EFSA TDIs. The HI calculations
based on anti-androgenicity alone did not result in HI values> 1. Thus,
considering the different years of sample collection and the different
modes of HI calculation, results for our children are in good accordance
to results for other child populations in Europe and populations in the
US confirming the consistent decline in cumulative exposure to anti-
androgenic phthalates to levels generally below a HI of 1.
4.2. Determinants of exposure
In a more in-depth investigation of the Portuguese data we laid
special focus on the two different groups of children in this study, one
group being overweight/obese children that had been set on a healthy
diet in a weight management program, and the other being normal-
weight children on their regular diet. As part of a larger study that was
originally designed to assess possible differences between these two
groups of children in regard to exposure to persistent environmental
chemicals, phthalates were included at a later stage. Thus, un-
fortunately, no urine samples were collected at the onset of the study
but only after the weight management program had already been in-
itiated for approximately 12 weeks (3 months). Therefore, we could not
evaluate the effect of the weight management program on urinary
phthalate levels within the group of obese/overweight children. We can
only compare the urinary phthalate levels of the obese/overweight
children already under dietary guidance to regular weight children
following their normal diet.
All urinary metabolite levels were higher in the regular diet group
compared to the healthy diet group, except for the DEP metabolite
MEP. However, these differences were only significant for the in-
dividual DEHP metabolites and the sum of DEHP metabolites, both in
μg/L and after creatinine adjustment. In both cases DEHP metabolites
were approximately 50% higher in the regular diet group compared to
the healthy diet group. In line with the results of the urinary metabolite
levels, calculated daily intakes were all higher in the regular diet group
(normal weight children) compared to the healthy diet group (obese/
overweight children). For daily intakes, all differences were statistically
significant except for DEP. Multiple log-linear regression analyses fur-
ther strengthened the above observed differences. Children in the
healthy diet group showed 38 % (for DiNP) to 49 % (for DEHP) lower
daily intakes of phthalates than children in the regular diet group.
Our findings are in contrast to recent studies reporting on associa-
tions of childhood exposure to some phthalates and adiposity/obesity.
Hatch et al., 2008, reported an increase in body mass index (BMI) and
waist circumference (WC) associated with urinary MEP concentrations
among adolescent girls. Teitelbaum et al., 2012 found similar associa-
tions for MEP and the sum of LMW phthalates (MEP, MnBP and MiBP)
for overweight children in the US. Three other studies found associa-
tions between the urinary levels of LMW phthalates and higher odds for
obesity in male children and adolescents (Buser et al., 2014), in non-
Hispanic blacks (Trasande et al., 2013a) or in girls aged 7–13 years
(Deierlein et al., 2016). In Chinese children (8–15 years old) MEHP and
MEP urinary levels, adjusted for age and sex, were positively associated
with BMI or waist circumference (WC) (Wang et al., 2013). Several
recent studies also evaluated prenatal phthalate exposure and child-
hood adiposity (Buckley et al., 2016a, 2016b; Harley et al., 2017;
Maresca et al., 2016; Valvi et al., 2015). Some report positive associa-
tions and others inverse associations between obesity-related markers
and prenatal phthalate exposures. Thus, more research is needed to
unveil or negate links between prenatal and/or childhood phthalate
exposures and childhood obesity.
One other study investigated urinary phthalate metabolite levels in
adults who lost weight through either bariatric surgery or a con-
servative weight loss program with dietary and lifestyle counselling
(Dirtu et al., 2013). They found no differences in metabolite levels and
profiles between the obese individuals entering the program and reg-
ular weight controls. Furthermore, they reported a slight increase in
urinary phthalate metabolite levels in parallel to the significant weight
loss after 3–6 months. To some extent, the findings by Dirtu et al.
(2013) contradict our findings of lower phthalate metabolite levels in
obese children in the weight management program. However, the two
studies are difficult to compare, because we only monitored the chil-
dren at the onset of the weight management program (3 months) before
a significant weight loss set in. Our weight management program was
especially based on a healthy green diet consisting of fresh, unprocessed
food, while the weight loss in the adult population of Dirtu et al. (2013)
was achieved by different weight loss strategies.
Our findings are in very good accordance with a wealth of past
studies that have identified contaminated food-stuff as a major con-
tributor to exposure to HMW phthalates such as DEHP and DiNP. For
DnBP, BBzP, DiBP and other LMW phthalates other sources (indoor
environment, personals care product use, etc.) have been reported as
additional contributors to exposure, often in a complex mixture of
sources and routes. The LMW phthalate DEP is generally regarded as
indicator to personal care product use (Ackerman et al., 2014; Colacino
et al., 2010; Cutanda et al., 2015; Ferguson et al., 2016; Fromme et al.,
2013; Hutter et al., 2016; Ji et al., 2010; Koch and Angerer, 2012; Koch
and Calafat, 2009; Koch et al., 2013; Larsson et al., 2014; Rudel et al.,
2011; Sathyanarayana et al., 2013; Serrano et al., 2014; Trasande et al.,
2013b; Wormuth et al., 2006). Our study strongly suggests that healthy
diet can have a significant effect on lowering exposures to both LMW
(except DEP) and HMW phthalates. This finding has also to be put into
context with the recent and rapid changes in market use of phthalates.
We show that our child population has exceptionally low exposures to
all phthalates compared to other populations investigated in earlier
years. Most probably, exposures to LMW phthalates (except DEP) from
personal care product use have dropped considerably due to a phase-
out in these products. With exposures from these sources eliminated,
other sources might surface as significant contributors such as con-
taminated foodstuff (or indoor environment), albeit at lower levels.
Thus, the most probable explanation for the observed differences be-
tween the healthy and the regular diet group is the healthy diet of the
obese/overweight children with focus on fresh unprocessed fruits and
vegetables, whole grains, low-fat and nonfat dairy products, beans, fish,
and lean meat. Additionally, the amount of calories was set according to
their nutritional needs (energy intake is appropriate for the main-
tenance of a normal weight for height and for the adequate intake of
micronutrients). Consequently, these children lowered their intake
amount of foodstuff in general and of processed, packaged and fat rich
foodstuff in special, probably with a combined effect on achieving
lower phthalate exposures. Nevertheless, we cannot separate the po-
tential phthalate reducing effects in regard to reduction in quantity of
the intake and the quality of the intake. Both are related to the term
“healthy diet”.
4.3. Limitations of the study
Certainly, this study has several important limitations. Due to study
design, we could not observe the direct effect of nutritional guidance on
urinary phthalate metabolites/daily intakes in the obese/overweight
children. For future studies, especially for studies with non-persistent
chemicals such as the phthalates, it would be advisable to collect
biospecimens (urine samples) before the onset of the special diet and
follow the trend of urinary metabolites during the course of study.
Because we could compare our results only to regular weight children
on their normal diet the actual differences in urinary metabolite levels/
daily intakes might have been even bigger if urine samples of the obese
children before starting the diet had been compared to their urine
samples during the special diet.
The study has only been based on a single first morning urine
sample from each child. Phthalate exposures are known to change over
the course of the day, but also significant between-day differences have
been shown (Frederiksen et al., 2013a; Koch et al., 2013; Preau et al.,
2010; Watkins et al., 2014). To calculate daily intakes from spot urine
samples we took account of the body height, the body weight and sex
based reference values for urinary creatinine excretion. These reference
values are derived from standard weight children (Remer et al., 2002)
and their applicability to obese/overweight children has not been
proven. Urinary flow rate and creatinine are known to be influence not
only by age and sex, but also by BMI category (Barr et al., 2005; Hays
et al., 2015). Urinary volume, urinary concentration and all calcula-
tions based on these measures (including daily intake calculations)
might be biased by the inherent physiological differences between the
obese/overweight and normal-weight children. To circumvent these
issues, full 24h-urine samples need to be collected.
Although it is generally accepted that phthalate metabolites are
rapidly metabolized and excreted after oral uptake with elimination
half times shorter than a day, a minor share of the daily phthalate dose
(or their metabolites) might accumulate in fatty tissues or other body
compartments (such as the skin) and re-mobilized or released during a
special diet or weight loss (Dirtu et al., 2013; Lorber and Koch, 2013).
Such secondary effects might therefore add additional complexities and
uncertainties to the extrapolation of urinary metabolite measures to
daily intakes especially if urinary metabolite/exposure differences be-
tween populations or sub-populations are rather small.
5. Conclusions
With this study we could provide recent and novel phthalate ex-
posure data for Portuguese children using the most extensive set of
phthalate exposure biomarkers available. We could confirm the still
ubiquitous exposure to a wide bandwidth of phthalates, but we could
also show that exposure levels were rather low, confirming the general,
worldwide trend to declining phthalate exposures, due to regulatory
measures and the substitution of phthalates with non-phthalate alter-
natives. Neither individual risk assessments nor the anti-androgenicity
based cumulative risk assessment indicated to health risks attributable
to phthalate exposure in our population investigated.
With this study we could also provide valuable insights into
phthalate exposures of children on a weight management program
compared to children on their regular diet. We conclude that the green
healthy diet, with a lot of fresh unprocessed food, resulted in the lower
exposures (approx. 50%) to most phthalates in the healthy diet group.
Only for DEP we suspect the use of personal care products as the
dominant source of exposure. However, we also have to voice some
words of caution. Obese and regular weight children differ strongly in
many physical characteristics (e.g. urine flow rate, urinary volume,
etc.) which can directly influence all measures ranging from urinary
metabolite concentration to body weight related calculated (daily) in-
takes. This might explain inconsistent findings of several previous stu-
dies on urinary phthalate levels in relation to obesity.
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